 InNexus Biotechnology, Inc. is a publicly held British Columbia Corporation (IXS) publicly traded since 2003 with laboratory operations on the campus of Mayo Clinic in Arizona. InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL™) technology, which improves the potency of existing antibody products and creates a novel class of antibody based drugs.
|
 Right around every third week of the month THIRDBIOTECH invites people from the Arizona biotechnology commmunity to trendy spots around town. A variety of industry professionals attend each month, including entrepreneurs, investors, attorneys, scientists and journalists. No lectures-no agenda. Some call it networking, others just good fun and the event offers both.
|
 Integrated Biomolecule Corporation (IBC) excels at providing analytical and pharmaceutical development services for both large and small molecules in a cGMP/GLP environment. IBC also provides custom organic synthesis services. Now in their 16th year, IBC is a sophisticated organization with a solid reputation for conducting great work and providing great service in a manner clients prefer.
|
 The Arizona Technology Council is the largest technology association in Arizona serving all tech sectors across the state. The Arizona Technology Council is a member-driven association. We represent the interests of technology companies, their support firms, educational institutions and state-wide economic development groups that collectively form Arizona’s technology community.
|